CB‐0821, a novel CC chemokine receptor 5 (CCR5) inhibitor with improved binding efficacy proposed as anti‐HIV candidate: Computational and in vitro approach

Documenti analoghi

• Human papillomavirus‐16 E6‐positive cervical cancer attenuated by potent 2‐(4‐biphenylyl)‐N‐(1‐ethyl‐4‐piperidinyl) acetamide second‐generation analogs with improved binding affinity
  di: Ashish Kumar
  Pubblicazione: (2024)
• Stability in human serum and plasma of the HIV peptide drug candidate CIGB‐210 and improved variants
  di: Carlos A. Duarte, et al.
  Pubblicazione: (2024)
• ZINC‐592 Ameliorates IgE‐Mediated Chronic Inflammatory Responses of Viral Infections via Keap1/Nrf2 Signaling
  di: Ashish Kumar
  Pubblicazione: (2025)
• Self‐assembled free nanocarrier prodrugs based on camptothecin and dihydroartemisinin exhibit accumulation and improved anticancer efficacy
  di: Mohan Garg, et al.
  Pubblicazione: (2024)
• In silico and in vitro evaluation of a PE38 and Nb‐based recombinant immunotoxin targeting the GRP78 receptor in cancer cells
  di: Mona Khoshbakht, et al.
  Pubblicazione: (2024)